Your browser doesn't support javascript.
loading
Impact of Reference and Target Region Selection on Amyloid PET SUV Ratios in the Phase 1b PRIME Study of Aducanumab.
Chiao, Ping; Bedell, Barry J; Avants, Brian; Zijdenbos, Alex P; Grand'Maison, Marilyn; O'Neill, Paul; O'Gorman, John; Chen, Tianle; Koeppe, Robert.
Affiliation
  • Chiao P; Biogen, Cambridge, Massachusetts ping-chun.chiao@biogen.com.
  • Bedell BJ; Biospective Inc., Montréal, Quebec, Canada.
  • Avants B; McGill University, Montréal, Quebec, Canada.
  • Zijdenbos AP; Biogen, Cambridge, Massachusetts.
  • Grand'Maison M; Biospective Inc., Montréal, Quebec, Canada.
  • O'Neill P; Biospective Inc., Montréal, Quebec, Canada.
  • O'Gorman J; Complete Medical Communications, Glasgow, United Kingdom; and.
  • Chen T; Biogen, Cambridge, Massachusetts.
  • Koeppe R; Biogen, Cambridge, Massachusetts.
J Nucl Med ; 60(1): 100-106, 2019 01.
Article in En | MEDLINE | ID: mdl-29777003

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Positron-Emission Tomography / Antibodies, Monoclonal, Humanized / Amyloid Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Language: En Journal: J Nucl Med Year: 2019 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Positron-Emission Tomography / Antibodies, Monoclonal, Humanized / Amyloid Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Language: En Journal: J Nucl Med Year: 2019 Document type: Article Country of publication: